Rep. Salazar Discloses MRNA Sale Amid Insider Activity
Hon. Maria Elvira Salazar, a member of the U.S. House of Representatives, has disclosed the sale of Moderna, Inc. (MRNA) common stock in a Periodic Transaction Report filed under the STOCK Act. The transaction, executed by the member personally through a UBS Brokerage Account, took place on August 19, 2026, and falls within the $1,001 … Read more